Phosphorylation of <scp>hTERT</scp> at threonine 249 is a novel tumor biomarker of aggressive cancer with poor prognosis in multiple organs

Yoko Matsuda(Aso Iizuka Hospital), Kenkichi Masutomi(National Cancer Centre Japan), Nobuyuki Miyatake(Kagawa University), Shinji Yamada(Tohoku University), Tsutomu Masaki(Kagawa University), Tomoyuki Yokose(Kanagawa Prefectural Hospital Organization), Mitsuhiro Machitani(The University of Osaka), Soichiro Morinaga(Kanagawa Prefectural Hospital Organization), Keiichi Okano(Kagawa University), Takeshi Kishida(National Institutes of Health), Nobuhiro Kanaji(Kagawa University), Hiroyuki Ito(Kanagawa Prefectural Hospital Organization), Taro Yamashita(Kanazawa University), Toshinari Minamoto(Kanazawa University), Mika K. Kaneko(Tohoku University), Yukinari Kato(Tohoku University), Masahiro Hirata(Kagawa University), Juanjuan Ye(Kagawa University), Shuichi Kaneko(Kanazawa University), Yohei Miyagi(Kanagawa Cancer Center), Mami Yasukawa(National Cancer Centre Japan), Motohiro Kojima(Chiba Cancer Center), Takashi Oshima(Kanagawa Prefectural Hospital Organization), Keiko Yamakawa(Kagawa University), Reiji Haba(Kagawa University), Yuri Mukai(Kagawa University), Yataro Daigo(The University of Tokyo), Keiichi Kontani(Kagawa University), Junko Takei(St. Luke's International Hospital)
The Journal of Pathology
January 30, 2022
Cited by 13


Related Papers